Our results demonstrated that insulin-TGF-β1 pathway impeded osteogenesis of BMSCs by inhibiting autophagy and promoting premature senescence, indicating a previously unknown mechanistic linkage of insulin-TGF-β receptor II (TβRII) pathway in T2DM associated bone disorders. Here, TGFB1 is linked to bone disorder.